Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 3 years ago You may also like 53:59 Dyne Therapeutics — Advancing DYNE-251, an Investigational Medicine for DMD 9 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 1:00:58 Navigating Steroid Choices: Understanding the Process, Pathways, and Policies 10 months ago Care Webinars,Webinars steroids 1:03:41 Community Update with Solid Biosciences on the New INSPIRE DUCHENNE Clinical Study of SGT-003 11 months ago Research & Clinical Trial Webinars,Webinars gene therapy,sgt-003,solid biosciences 59:54 Overview of Topline Results from Phase 3 EMBARK Study 1 year ago Research & Clinical Trial Webinars,Webinars sarepta 25:01 Advocating for Access: Overview of Medicaid DUR and P&T Meetings 1 year ago Care Webinars,Webinars feature,insurance,medicaid 54:28 Capricor Therapeutics: CAP-1002 HOPE-3 Program Update 1 year ago Research & Clinical Trial Webinars,Webinars capricor 49:31 Edgewise Therapeutics: A Novel Approach Designed to Protect Muscle in Becker Muscular Dystrophy 1 year ago Research & Clinical Trial Webinars,Webinars edg-5506,edgewise 59:38 Supporting Families Through Decision Making 1 year ago Care Webinars,Webinars palliative care «12345…25»Page 3 of 25
by: Parent Project Muscular Dystrophy
